Literature DB >> 7677475

Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass.

B M Steinberg1, E A Grossi, D S Schwartz, D E McLoughlin, M Aguinaga, C Bizekis, J Greenwald, A Flisser, F C Spencer, A C Galloway.   

Abstract

BACKGROUND: Heparin bonding of the cardiopulmonary bypass (CPB) pump circuit decreases complement activation and fibrinolysis. It is not known whether inflammatory cytokines produced during CPB can also be modulated by the more biocompatible heparin-coated circuit.
METHODS: This initial study evaluated the impact of heparin-bonded CPB circuits on production of the cytokines interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-a), IL-6, and IL-8 in adults undergoing complex cardiac operations with prolonged CPB. Twenty patients had blood samples drawn immediately before and at hourly intervals after the start of CPB using either a conventional oxygenator and circuit (n = 14) or a covalently bonded heparin oxygenator and circuit (n = 6). Levels of IL-1, TNF-a, IL-6, and IL-8 were measured in all serum samples using a "sandwich" enzyme-linked immunosorbent assay.
RESULTS: The levels of IL-6 and IL-8 increased in a time-dependent fashion in both groups, but the response was significantly less over time in the heparin-bonded group (p < 0.05) for both IL-6 and IL-8. Levels of IL-1 and TNF-a were not significantly elevated with lengthening bypass interval in either group.
CONCLUSIONS: These data indicate that the use of heparin-coated bypass pump circuits results in lower serum levels of the inflammatory cytokines IL-6 and IL-8 than standard circuits. Biocompatible materials that decrease the inflammatory response to CPB may ultimately reduce the morbidity associated with cardiac operations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7677475     DOI: 10.1016/0003-4975(95)00482-z

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Superior biocompatibility of heparin-bonded circuits in pediatric cardiopulmonary bypass.

Authors:  T Ozawa; K Yoshihara; N Koyama; S Yamazaki; Y Takanashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-12

Review 2.  Neurocognitive Function after Cardiac Surgery: From Phenotypes to Mechanisms.

Authors:  Miles Berger; Niccolò Terrando; S Kendall Smith; Jeffrey N Browndyke; Mark F Newman; Joseph P Mathew
Journal:  Anesthesiology       Date:  2018-10       Impact factor: 7.892

3.  Interindividual variations in cytokine levels following cardiopulmonary bypass.

Authors:  M Misoph; J Babin-Ebell
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

4.  Cytokine balance in hepatosplanchnic system during thoracoabdominal aortic aneurysm repair.

Authors:  Takashi Kunihara; Suguru Kubota; Norihiko Shiiya; Kenji Iizuka; Shigeyuki Sasaki; Satoru Wakasa; Kenji Matsuzaki; Yoshiro Matsui
Journal:  J Artif Organs       Date:  2011-06-24       Impact factor: 1.731

5.  Percutaneous cardiopulmonary support with heparin-coated circuits in postcardiotomy cardiogenic shock. Efficacy and comparison with left heart bypass.

Authors:  Y Hayashi; S Ohtake; Y Sawa; M Nishimura; H Ichikawa; H Satoh; T Yamaguchi; H Suhara; T Sakaguchi; H Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-05

6.  Plasma macrophage colony-stimulating factor levels during cardiopulmonary bypass with extracorporeal circulation.

Authors:  Y Denizot; P Fixe; E Cornu; N Nathan
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

7.  Alpha lipoic acid attenuates inflammatory response during extracorporeal circulation.

Authors:  Ihsan Sami Uyar; Suleyman Onal; M Besir Akpinar; Ibak Gonen; Veysel Sahin; Abdulhadi Cihangir Uguz; Oktay Burma
Journal:  Cardiovasc J Afr       Date:  2013-09       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.